Pharmacological options in the treatment of benign prostatic hyperplasia

  • J Med Chem. 1997 Apr 25;40(9):1293-315. doi: 10.1021/jm960697s.
B Kenny  1 ,  S Ballard ,  J Blagg ,  D Fox
Affiliations
  • 1. Department of Discovery Biology, Pfizer Central Research, Sandwich, Kent, UK.
PMID: 9135028 DOI: 10.1021/jm960697s
Products